Notice - Prescription Drug List (PDL): Hydrocortisone

The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List (PDL).

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:24 (UTC)
Created April 17, 2026, 21:24 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-04 00:00:00
open_canada_keywords {"fr": ["Hydrocortisone", "avis", "avis de modification", "liste de médicaments sur ordonnance", "PDL", "liste révisée"], "en": ["Hydrocortisone", "notice", "notice of amendment", "prescription drug list", "PDL", "revised listing"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis - Liste des drogues sur ordonnance (LDO) : Hydrocortisone
update_frequency as_needed